Amundi
HAE icon

Amundi’s Haemonetics HAE Stock Holding History

Amundi’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$284K Sell
3,780
-2,063
-35% -$133K ﹤0.01% 1862
2026
Q1 		$329K Buy
5,843
+3,077
+111% +$200K ﹤0.01% 1714
2025
Q4 		$222K Buy
+2,766
New +$186K ﹤0.01% 1729
2025
Q2 		– Sell
-37
Closed -$2.3K – 1881
2025
Q1 		$2.3K Buy
37
+2
+6% +$136 ﹤0.01% 1950
2024
Q4 		$2.73K Buy
+35
New +$2.81K ﹤0.01% 1971
2022
Q1 		– Sell
-46,385
Closed -$2.42M – 1672
2021
Q4 		$2.42M Buy
46,385
+1,925
+4% +$117K ﹤0.01% 1157
2021
Q3 		$3.14M Sell
44,460
-454
-1% -$28.6K ﹤0.01% 1117
2021
Q2 		$2.99M Buy
+44,914
New +$3.18M ﹤0.01% 1100

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amundi's HAE Position: Q2 2026 in Review

Amundi reduced its Haemonetics (HAE) stake by 35% in Q2 2026, selling an estimated $133K and leaving 3,780 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #1862.

Amundi first reported a position in HAE in Q2 2021 and has held it in 8 quarters since. The position peaked at $3.14M in Q3 2021. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Amundi held 3,780 shares of Haemonetics worth $284K as of Q2 2026.
  • Amundi sold 2,063 Haemonetics shares in Q2 2026, an estimated $133K.
  • Haemonetics made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1862 holding.
  • Amundi first reported a position in Haemonetics in Q2 2021 and has held it in 8 quarters since.
  • Amundi's Haemonetics position peaked at $3.14M in Q3 2021.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.